VEGFA and neoplasm: We then examined the regulators of vascularization in the tumor and found that the levels of VEGF-A were significantly reduced in NDV-D90-treated tumor, compared to control, by ELISA (Figure 6C) and by immunohistochemistry (Figure 6D).